MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer
Xiaoqian Yang(Hebei University), Zhenfeng Duan(University of Miami)
Cited by 156
Related Papers
Novel strategies to prevent the development of multidrug resistance (MDR) in cancer
|Oncotarget|2017|208
Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma
|BMC Cancer|2009|161
Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma
|Oncotarget|2015|103